KHN Editor-in-Chief Elisabeth Rosenthal appeared on to discuss the bottlenecks that have prevented doses of precious covid-19 vaccine from making it from drugmakers’ factories into patients’ arms. It didn’t have to be this way, she explains.
The independent source for health policy research, polling, and news.